15-77037138-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_003978.5(PSTPIP1):c.1213C>T(p.Arg405Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000599 in 1,611,742 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003978.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSTPIP1 | NM_003978.5 | c.1213C>T | p.Arg405Cys | missense_variant | Exon 15 of 15 | ENST00000558012.6 | NP_003969.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000568 AC: 140AN: 246402Hom.: 0 AF XY: 0.000581 AC XY: 78AN XY: 134350
GnomAD4 exome AF: 0.000608 AC: 887AN: 1459524Hom.: 1 Cov.: 31 AF XY: 0.000558 AC XY: 405AN XY: 726006
GnomAD4 genome AF: 0.000519 AC: 79AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74416
ClinVar
Submissions by phenotype
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome Uncertain:1Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
The PSTPIP1 c.1213C>T; p.Arg405Cys variant (rs201253322, ClinVar variation ID: 242307), is reported in the literature in at least one individual affected with pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome (Calderon-Castrat 2016), and in multiple individuals affected with pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (Starnes 2014, Stone 2022). This variant has also been reported in an individual with an autoinflammatory syndrome, hemophagocytic lymphohistiocytosis (Gowin 2021) and in an individual with hidradenitis suppurativa (Morales-Heil 2023). It is observed in the general population with an overall allele frequency of 0.057% (158/277726 alleles) in the Genome Aggregation Database (v2.1.1). Computational analyses predict that this variant is neutral (REVEL: 0.056). However, functional analyses of the variant protein show reduced binding of PSTPIP1 to WASp (Starnes 2014, Morales-Heil 2023). Due to conflicting information, the clinical significance of the p.Arg405Cys variant is uncertain at this time. References: Calderon-Castrat X et al. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2016 Jul;175(1):194-8. PMID: 26713508 Gowin E et al. Mutation in the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene in a patient with acute lymphoblastic leukemia. Cent Eur J Immunol. 2021;46(2):270-274. PMID: 34764798. Morales-Heil DJ et al. Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa. HGG Adv. 2023 Mar 13;4(2):100187. PMID: 37013170. Starnes TW et al. The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages. Blood. 2014 Apr 24;123(17):2703-14. PMID: 24421327 Stone DL et al. Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1. Arthritis Rheumatol. 2022 Feb;74(2):353-357. PMID: 34492165. -
- -
not provided Uncertain:1
Published functional studies demonstrate that R405C may alter the interaction of PSTPIP1 with cytoskeleton and cell migration regulators (Starnes et al., 2014); In silico analysis supports that this missense variant does not alter protein structure/function; This substitution does not occur in the coiled-coil domain region, the region where definitive PAPA-associated variants have been identified to date.; This variant is associated with the following publications: (PMID: 24764557, 27106250, 26713508, 30619323, 24421327, 32909274, 34764798, 32942279) -
Autoinflammatory syndrome Uncertain:1
- -
PSTPIP1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at